Viking Therapeutics Set to Showcase Innovations at Major Investor Conferences in New York

Viking Therapeutics to Present at Key Investor Conferences

Viking Therapeutics, Inc. (NASDAQ: VKTX), a biopharmaceutical company engaged in developing innovative treatments for metabolic and endocrine disorders, is gearing up to participate in several significant investor conferences this September. This announcement underscores the company's commitment to transparency and communication with the investment community.

Conference Participation Details

Viking's management team will actively engage with potential investors at a series of high-profile conferences held in New York City. The details of these events are as follows:

1. Cantor Global Healthcare Conference
- Dates: September 3-5, 2025
- Fireside Chat: September 5 from 9:45 AM to 10:15 AM Eastern Time
- Location: New York, NY

2. Morgan Stanley 23rd Annual Global Healthcare Conference
- Dates: September 8-10, 2025
- Fireside Chat: September 8 from 3:20 PM to 3:55 PM Eastern Time (available via webcast)
- Location: New York, NY

3. Bernstein's 2nd Annual Healthcare Forum
- Dates: September 23-25, 2025
- Presentation: September 23 from 11:20 AM to 12:00 PM Eastern Time (available via webcast)
- Location: New York, NY

4. Stifel Virtual Cardiometabolic Forum
- Date: September 30, 2025
- Location: Virtual

Live webcasts of both the Morgan Stanley fireside chat and the Bernstein presentation will be accessible through the Viking Therapeutics website under the